Tirzepatide May Be a Better Fit If: Maximum weight loss is your primary goal, and tirzepatide consistently produces greater reductions in clinical data You have type 2 diabetes and want superior blood sugar control (SURPASS-2 showed clear superiority over semaglutide) You've tried semaglutide and plateaued, and the dual-agonist mechanism may produce additional response You respond well to lower doses, and tirzepatide 5mg matches semaglutide 2.4mg for weight loss Semaglutide May Be a Better Fit If: Cardiovascular protection is important, as the SELECT trial provides strong evidence for heart benefit You prefer an oral option: oral semaglutide exists (the Ozempic pill for diabetes, which reformulated and renamed Rybelsus in 2026, and the Wegovy pill for weight)
The science is clear and growing more concerning as long-term data accumulates
When GLP-1 receptor agonists are combined with insulin or sulfonylureas, the doses of these medications may need to be reduced to avoid hypoglycemia
Proc Natl Acad Sci 112(8):25092514 Pu J, Fang FF, Li XQ, Shu ZH, Jiang YP, Han T, Peng W, Zheng CJ (2016) Matrine exerts a strong anti-arthritic effect on type II collagen-induced arthritis in rats by inhibiting inflammatory responses
